Piramal Critical`s sugammadex Receives Approval in Europe
MUMBAI, India, June 6, 2023 /PRNewswire/ -- Piramal Pharma Limited's (NSE: PPLPHARMA) (BSE: 543635) Piramal Critical Care (PCC) business, a producer of Inhaled Anesthetics and a global player in hospital generics, today announced the appointment of Jeffrey Hampton as President & Chief Operating Officer (COO). For his new role, Mr. Hampton will be based in the United States.
Piramal's Generic Dicyclomine Hydrochloride Receives Approval in the U.S.
MUMBAI, India, Nov. 17, 2022 /PRNewswire/ -- Piramal Critical Care (PCC) has integrated its sustainability framework with its strategy as well as daily business practices. As part of the endeavour, PCC's Environment, Social and Governance (ESG) policy covers sustainable and environment-friendly practices across energy and waste management, climate change management, greenhouse gas (GHG) reduction, water stewardship, supplier assessment, and integration of sustainability into our operations to ensure continual improvement in our performance and employee engagement. PCC is the complex hospital generics business under Piramal Pharma Limited (PPL). PCC's commitment towards sustainability dovetails into the overall objective of integrating sustainable practices across all businesses under PPL, as articulated in PPL's Sustainability Report FY 21–22.
Piramal Critical Care Launches First to Market Generic Zinc Sulfate Injection in the U.S.
Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announces First to Market Generic U.S. launch of Zinc...
Piramal Enterprises (PEL) has received shareholders’ approval for the proposed demerger of its pharmaceuticals business and simplification of the corporate structure. They supported the move with a whopping 99.99% votes.
Enforcement Report- Week of October 27, 2021